Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nemiralisib (GSK2269557) in COPD
NCT02130635Phase 2Completed
- Sponsor
- GSK
- Start
- Jul 2014
- Primary completion
- Aug 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nemiralisib in chronic obstructive pulmonary disease (COPD), sponsored by GSK. Started Jul 2014; status: completed.
02
Drugs
nemiralisib
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT02130635.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02130635.